Close
ACHEMA MIDDLE EAST 2026

GlycoMimetics Reports Top-line Results From Pfizers Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease

GlycoMimetics, Inc. reported that Pfizer Inc.  announced that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge (RESET) pivotal study did...

GSK grants exclusive technology license for clinical stage Ebola vaccines to Sabin Vaccine Institute

GSK and the Sabin Vaccine Institute announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola...

Sernova Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data

Sernova Corp, a clinical-stage regenerative medicine company announced that its human Phase I/II clinical trial for type-1 diabetes is advancing with additional patients for...

Orphazyme completes enrollment in phase 3 trial evaluating arimoclomol in amyotrophic lateral sclerosis

Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases announces that it has completed enrollment in its phase...

LYNPARZA delivers 72per ORR in phase 3 SOLO3 trial in advanced ovarian cancer

AstraZeneca and Merck presented full results from the Phase 3 SOLO3 trial which evaluated LYNPARZA, compared to chemotherapy, for the treatment of platinum-sensitive relapsed...

ProtoKinetix achieves primary objective safety at midpoint of clinical trial

ProtoKinetix, announced reaching the midpoint of a Phase-1 first-in-human clinical trial of AAGP PKX-001 treated islet cells used in conjunction with the Edmonton Protocol...

ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research

ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today announced that it has...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...